Oppenheimer Reiterates Outperform on Icosavax, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Hartaj Singh has reiterated an 'Outperform' rating on Icosavax (NASDAQ:ICVX) and maintained a $25 price target.
October 02, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer analyst Hartaj Singh has reiterated an 'Outperform' rating on Icosavax and maintained a $25 price target.
The reiteration of an 'Outperform' rating by Oppenheimer analyst Hartaj Singh indicates a positive outlook for Icosavax. The maintained price target of $25 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100